Strata skin sciences to participate in the benchmark healthcare house call virtual 1x1 investor conference

Horsham, pa., may 13, 2024 (globe newswire) -- strata skin sciences, inc. (“strata” or the “company”) (nasdaq: sskn), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that dr. dolev rafaeli, president and chief executive officer, and christopher lesovitz, chief financial officer, will participate in the benchmark healthcare house call virtual 1x1 investor conference being held on may 21 – 22, 2024.
SSKN Ratings Summary
SSKN Quant Ranking